Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting
Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older
New Therapies Could Benefit Patients With Difficult Cancers
Radiation Improves Survival In Advanced Prostate Cancer
Survivors With Gene Variant At More Risk For Heart Disease
ASCO, FDA Website To Help Demystify Expanded Access
NCI Trials Listed
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









